Food Allergy Research and Resource Program, University of Nebraska-Lincoln , 143 Food Industry Complex, Lincoln, Nebraska 68583-0955, United States.
J Agric Food Chem. 2013 Sep 4;61(35):8317-32. doi: 10.1021/jf400952y. Epub 2013 Jul 25.
The safety of food produced from genetically engineered (GE) crops is assessed for potential risks of food allergy on the basis of an international consensus guideline outlined by the Codex Alimentarius Commission (2003). The assessment focuses on evaluation of the potential allergenicity of the newly expressed protein(s) as the primary potential risk using a process that markedly limits risks to allergic consumers. However, Codex also recommended evaluating a second concern, potential increases in endogenous allergens of commonly allergenic food crops that might occur due to insertion of the gene. Unfortunately, potential risks and natural variation of endogenous allergens in non-GE varieties are not understood, and risks from increases have not been demonstrated. Because regulatory approvals in some countries are delayed due to increasing demands for measuring endogenous allergens, we present a review of the potential risks of food allergy, risk management for food allergy, and test methods that may be used in these evaluations. We also present new data from our laboratory studies on the variation of the allergenic lipid transfer protein in non-GE maize hybrids as well as data from two studies of endogenous allergen comparisons for three GE soybean lines, their nearest genetic soy lines, and other commercial lines. We conclude that scientifically based limits of acceptable variation cannot been established without an understanding of natural variation in non-GE crops. Furthermore, the risks from increased allergen expression are minimal as the risk management strategy for food allergy is for allergic individuals to avoid consuming any food containing their allergenic source, regardless of the crop variety.
经基因工程(GE)改造的作物所生产的食品的安全性,是根据食品法典委员会(2003 年)概述的国际共识准则,评估其发生食物过敏的潜在风险。该评估侧重于使用一种明显降低过敏消费者风险的过程,评估新表达蛋白的潜在致敏性作为主要潜在风险。然而,法典还建议评估第二个问题,即由于基因插入可能导致的常见致敏性食物作物内源性过敏原的潜在增加。不幸的是,对于非转基因品种中内源性过敏原的潜在风险和自然变异,人们并不了解,也没有证明增加的风险。由于一些国家因需要增加对内源性过敏原的测量而导致监管批准延迟,我们对食物过敏的潜在风险、食物过敏风险管理以及可能用于这些评估的测试方法进行了综述。我们还介绍了我们实验室关于非转基因玉米杂种中变应原脂质转移蛋白变异的研究新数据,以及对三种转基因大豆品系及其最接近的遗传大豆品系以及其他商业品系的内源性过敏原比较的两项研究的数据。我们的结论是,如果不了解非转基因作物的自然变异,就无法确定可接受变异的科学依据。此外,由于食物过敏风险管理策略是让过敏个体避免食用任何含有其致敏源的食物,因此增加过敏原表达的风险很小,无论作物品种如何。